In recent years, CRO has developed rapidly in China, and has played an important role in improving the level of Chinese clinical trials and drug development. However, the development of CRO industry also has problems. This paper discusses the beneficial factors of the main problems and the future direction of CRO, in attempt to attract the attention of government supervision and management departments and CRO industries.
Citation: LEI Xiang, WANG Xiaohui, LI Jing, WANG Bei, ZHAO Chen, YU Jiajie, LI Youping, WU Taixiang, BIAN Zhaoxiang, SHANG Hongcai. Development and changes of CRO of clinical trials in China. Chinese Journal of Evidence-Based Medicine, 2018, 18(8): 783-786. doi: 10.7507/1672-2531.201804083 Copy